Eleonora Nicolò, Instructor of Cancer Research in Medicine at Weill Cornell Medicine, shared on LinkedIn:
“Our new paper is now published in ESMO Open!
This study provides further evidence of the clinical relevance of tdEVs in patients with metastatic breast cancer and highlights how their combination with CTCs improves risk stratification compared with either biomarker alone.
These findings support the potential of an integrated approach to enable more precise and personalized clinical decision-making across different clinical settings.
Grateful to all co-authors and collaborators for their essential contributions to this work: Carolina Reduzzi, Massimo Cristofanilli, François-Clément Bidard, José L. Sandoval, Shufang RENAULT, Letizia Pontolillo, Mara Serena Serafini, Giuseppe Curigliano, Lorenzo Gerratana.”
Title: Combining circulating tumor cells and tumor-derived extracellular vesicles for prognosis stratification in patients with metastatic breast cancer
Authors: E. Nicolò, J.L. Sandoval, L. Foffano, S. Cyrille, W. Lei, R. Arpino, F. Berger, L. Munoz-Arcos, L. Pontolillo, M.S. Serafini, C. Gianni, N. Bayou, A.A. Davis, H. Liu, W.J. Gradishar, G. Curigliano, L. Gerratana, X.K. Zhou, S. Renault, M. Cristofanilli, F.-C. Bidard, C. Reduzzi
Other articles about breast cancer on OncoDaily.